Invention Grant
- Patent Title: Treatment of cancer using recall antigens delivered by attenuated bacteria
-
Application No.: US15568491Application Date: 2016-04-26
-
Publication No.: US11213577B2Publication Date: 2022-01-04
- Inventor: Claudia Gravekamp
- Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
- Applicant Address: US NY Bronx
- Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
- Current Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
- Current Assignee Address: US NY Bronx
- Agent Timothy J. Bortree
- International Application: PCT/US2016/029283 WO 20160426
- International Announcement: WO2016/176164 WO 20161103
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K39/00 ; A61K35/74 ; C07K14/33 ; C07K14/005 ; A61K39/08 ; A61P35/04 ; A61K39/39 ; A61K45/00 ; C07K14/105 ; C07K14/12 ; C12N1/36
Abstract:
Methods, pharmaceutical compositions and vaccines comprising an attenuated bacteria that expresses a recall antigen are disclosed for treatment of cancer.
Public/Granted literature
- US20180104320A1 TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA Public/Granted day:2018-04-19
Information query
